<unk>  is an acronym for relatively intensive chemotherapy regimen that is used for salvage therapy in relapsed or refractory lymphomas and Hodgkin's lymphoma. In combination with monoclonal antibody Rituximab it is called R-ESHAP or<unk> -R. R-ESHAP consists of: # Rituximab, an anti-CD20-directed monoclonal antibody that kills both normal and malignant B-lymphocytes # Etoposide, an epipodofyllotoxin topoisomerase inhibitor # Solu-Medrol - Methylprednisolone, which is a glucocorticoid that can lyse lymphocytes # High-dose Ara-C - cytarabine # Platinol - Cisplatin, a platinum-based antineoplastic agent, also an alkylating antineoplastic agent.
ESHAP
Zero-COVID
Toxicon
COVID-19
Long COVID
Croup
Swine influenza
Anthrax